Point-of-Care Testing (POCT)

Point-of-care testing is laboratory analysis performed near the patient - at the bedside, in a clinic, in an emergency department, or in the community - rather than in a central laboratory, with the aim of producing a result fast enough to inform an immediate decision. Its defining promise is shortened turnaround time, and its defining challenge is holding decentralized testing to the same quality standards as the central laboratory.

Definition

Point-of-care testing is clinical laboratory testing carried out at or near the site of patient care, outside the physical facilities of a central laboratory, in order to provide a result rapidly enough to support an immediate clinical decision.

Scope

This topic covers what distinguishes point-of-care testing from central-laboratory testing, the trade-off between turnaround time and analytical and operational control, the governance needed when testing is performed by non-laboratory staff, and the standards and oversight that keep results reliable. It is a methodological reference within laboratory quality and does not instruct on operating any specific device or interpreting an individual result.

Core questions

• What does point-of-care testing offer that central-laboratory testing cannot, and at what cost?
• How is analytical quality maintained when testing is decentralized and operated by non-laboratory staff?
• What governance and oversight structures are needed for point-of-care testing?
• When does faster turnaround translate into better clinical decisions?

Key concepts

• Turnaround time and clinical decision-making
• Decentralized vs. central-laboratory testing
• Operator competency and training
• Connectivity and result documentation
• Quality control and external quality assessment for POCT
• Governance and oversight (POCT committee)
• Standards (ISO 22870, ISO 15189)
• Total testing process at the point of care

Mechanisms

Point-of-care testing achieves rapid results by moving compact analytical devices to the patient and eliminating specimen transport and central-laboratory queuing, so that measurement and clinical action are brought close together in time. This decentralization changes where the quality risks lie: testing is often performed by staff whose primary role is not laboratory work, so quality depends heavily on standardized procedures, operator training and competency assessment, device-level quality control, participation in external quality assessment, and connectivity that captures results in the patient record. Because the pre-analytical and post-analytical steps are compressed and distributed, oversight typically rests with a multidisciplinary governance structure that extends central-laboratory quality systems to every testing site.

Clinical relevance

By shortening turnaround time, point-of-care testing can support faster decisions in settings such as emergency and critical care, but the value of a faster result depends on whether it actually changes management, and decentralization introduces quality risks that must be governed. This topic describes how point-of-care testing is structured and overseen; it characterizes laboratory practice and is not guidance for diagnosing or treating an individual patient.

Evidence & guidelines

Quality and competence requirements specific to point-of-care testing are set out in ISO 22870, which is applied together with the general medical-laboratory standard ISO 15189. Overview articles by Price and others frame the benefits and quality challenges of decentralized testing, and more recent reviews address validation and implementation of emerging point-of-care technologies. Evidence on whether faster turnaround improves clinical outcomes is mixed and depends on the care setting.

History

Bedside and near-patient measurements such as urine and blood glucose testing long predate the modern concept, but point-of-care testing emerged as a defined discipline as portable analyzers for blood gases, cardiac markers, and coagulation spread through the 1990s and 2000s. As decentralized testing grew, concern about uneven quality led to dedicated standards and governance structures, articulated in reviews by Price and in standards such as ISO 22870, extending central-laboratory quality systems to the point of care.

Debates

Does faster turnaround time improve patient outcomes?

Point-of-care testing reliably shortens the time to a result, but whether that translates into better clinical outcomes depends on whether the result changes management in a given setting; evidence is mixed, and the analytical and cost trade-offs against central-laboratory testing remain contested.

How to assure quality with non-laboratory operators

Decentralized testing by clinical staff raises the risk of operator error and inconsistent quality control; how much training, competency assessment, connectivity, and central oversight are needed to match central-laboratory reliability is an ongoing governance question.

Key figures

• Christopher P. Price
• Gerald J. Kost
• Larry J. Kricka

Seminal works

• price-2001
• wang-2018

Frequently asked questions

How is point-of-care testing different from central-laboratory testing?

Point-of-care testing is performed near the patient rather than in a central laboratory, trading the central laboratory's controlled environment and specialized staff for much faster turnaround time. It is held to the same quality standards, but the quality risks shift toward operator competency, device-level control, and oversight of many testing sites.

Does a faster result always mean better care?

Not necessarily. Point-of-care testing reliably shortens turnaround time, but a faster result improves care only when it actually changes a clinical decision. Its benefit depends on the setting, and it must be weighed against analytical and cost considerations relative to central-laboratory testing.